Professional Planning’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$820K Buy
7,604
+472
+7% +$53.9K 0.39% 54
2021
Q2
$803K Sell
7,132
-264
-4% -$29.7K 0.37% 53
2021
Q1
$800K Sell
7,396
-4,344
-37% -$465K 0.39% 51
2020
Q4
$1.26M Buy
11,740
+578
+5% +$55.5K 0.51% 38
2020
Q3
$978K Buy
11,162
+1,527
+16% +$144K 0.75% 26
2020
Q2
$946K Buy
+9,635
New +$848K 0.5% 44

Other funds holding ABBV

Professional Planning's ABBV Position: Q3 2021 in Review

Professional Planning increased its AbbVie (ABBV) stake by 6.6% in Q3 2021, buying an estimated $53.9K and bringing the position to 7,604 shares worth $820K. The position accounts for 0.39% of the portfolio, ranked #54.

Professional Planning first reported a position in ABBV in Q2 2020 and has held it in 6 quarters since. The position peaked at $1.26M in Q4 2020. 2,654 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.

  • Professional Planning held 7,604 shares of AbbVie worth $820K as of Q3 2021.
  • Professional Planning bought 472 AbbVie shares in Q3 2021, an estimated $53.9K.
  • AbbVie made up 0.39% of Professional Planning's portfolio in Q3 2021, its #54 holding.
  • Professional Planning first reported a position in AbbVie in Q2 2020 and has held it in 6 quarters since.
  • Professional Planning's AbbVie position peaked at $1.26M in Q4 2020.
  • 2,654 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.

Based on Professional Planning's 13F filing for Q3 2021, filed 15 Nov 2021.